Hiroyuki Hashi

633 citations
11 papers · 530 indexed · h-index 6
Topics
Vascular Tumors and Angiosarcomas (2 papers)Immune Response and Inflammation (2 papers)Lymphatic System and Diseases (2 papers)

In The Last Decade

Hiroyuki Hashi

11 papers receiving 517 citations

Peers

Hiroyuki Hashi
Comparison fields: 5 of 55
  • Molecular Biology 248
  • Oncology 247
  • Immunology 219
  • Surgery 79
  • Physiology 60
Replace Kathryn Koprivnikar with:
Kathryn Koprivnikar United States
Qian‐Lin Hao United States
Y Shabo Israel
F W Jacobsen Norway
Lisa L. Kohli United States
Xianfeng Fang China
Francesca Rucci United States
Paula A. Clark United Kingdom
Weiqi Huang United States
Dirk Carstanjen Germany
Hiroyuki Hashi relative to Kathryn Koprivnikar United States Kathryn Koprivnikar's profile →
Citations per field
00.5×1.6×
Kathryn Koprivnikar · 1×
Citations per year

Countries citing papers authored by Hiroyuki Hashi

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Hashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Hashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Hashi more than expected).

Fields of papers citing papers by Hiroyuki Hashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Hashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Hashi. The network helps show where Hiroyuki Hashi may publish in the future.

Co-authorship network of co-authors of Hiroyuki Hashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Hashi. A scholar is included among the top collaborators of Hiroyuki Hashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Hashi. Hiroyuki Hashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 4
2 1
3 1
4 116
5 76
6 54
7 178
8 2
9 70
10 25
11
[The effect of the superoxide reaction on diabetic cataract formation].
3

About Hiroyuki Hashi

Hiroyuki Hashi is a scholar working on Immunology and Allergy, Biochemistry and Endocrine and Autonomic Systems, having authored 11 papers that have together received 530 indexed citations. Recurring topics across this work include Vascular Tumors and Angiosarcomas (2 papers), Immune Response and Inflammation (2 papers) and Lymphatic System and Diseases (2 papers). The work is most often cited by research in Immunology (219 citations), Oncology (247 citations) and Immunology and Allergy (22 citations). Hiroyuki Hashi has collaborated with scholars based in Japan, Finland and United States. Frequent co-authors include Hisahiro Yoshida, Kenya Honda, Shin‐Ichi Nishikawa, Hajime Kubo, Masaaki Awane, Yoshio Yamaoka, Arimichi Takabayashi, Minetaro Ogawa, Takashi Fujiwara and Yoshiharu Sakai. Their work appears in journals such as Blood, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026